Agrisera

Executive Summary

Agrisera is a Swedish biotechnology company established in 2001, specializing in the development, production, and global distribution of high-quality research antibodies. The company's primary focus is on antibodies for plant and algal research, where it has built a strong reputation for reagents with broad species reactivity and extensive publication records. In addition to its plant-focused offerings, Agrisera provides antibodies for human cell biology and other species, catering to a diverse range of life science researchers. The company emphasizes fast delivery and comprehensive technical support, positioning itself as a reliable partner for academic and industrial laboratories worldwide. With its niche specialization in plant and algal antibodies, Agrisera occupies a unique position in the competitive antibody market. The company's commitment to quality and customer service has enabled it to build a loyal customer base and achieve strong brand recognition among plant biologists. As the demand for plant-based research tools grows—driven by trends in sustainable agriculture, climate change studies, and biofuel development—Agrisera is well-positioned to capitalize on these opportunities. Recent expansions into human cell biology and other species suggest a strategic diversification that could broaden its revenue streams. While the company remains private with limited public financial data, its consistent presence in the research community and positive customer feedback indicate a stable and potentially growing business.

Upcoming Catalysts (preview)

• Q3 2026Expansion of antibody portfolio into new plant species and model organisms70% success
• Q4 2026Formation of strategic partnerships with agricultural biotech or pharmaceutical firms50% success
• TBDLaunch of antibodies targeting emerging human disease biomarkers40% success